Interestingly, this impairment in LTP is reminiscent of our previously reported findings in the methyl-CpG binding protein 2 (MECP2)-deficient mouse model of Rett syndrome [53], and MECP2 is a downstream target of LTCCs [54]. This evidence concerns the gene MECP2 and Rett syndrome.